Neurocrine Bioscience buy Wedbush
Start price
31.07.25
/
50%
€115.25
Target price
31.07.26
€123.35
Performance (%)
-0.65%
Price
11:33
€114.50
Summary
This prediction is currently active. The BUY prediction by Wedbush for Neurocrine Bioscience is nearly unchanged. This prediction currently runs until 31.07.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.750% | -2.750% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by Wedbush for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Wedbush from $137.00 to $141.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Wedbush for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.50
07.02.25
07.02.25
€142.21
07.02.26
07.02.26
-1.97%
11:33
11:33
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.25
16.12.24
16.12.24
€140.81
16.12.25
16.12.25
2.19%
17.12.25
17.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.80
29.05.24
29.05.24
€140.10
29.05.25
29.05.25
-10.86%
30.05.25
30.05.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€127.63
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24